The Cell Based Assay Market size is expected to grow at an annual average of 7% during 2021-2027. Cell-based assays encompass a variety of assays that measure cellular parameters such as cytotoxicity, proliferation, marker generation, activation of specific signaling pathways, and motility and morphological changes. Ideal for miniaturization as it is used for signal amplification of cell signaling cascades. Cell-based assays are widely applied as a high-throughput screening (HTS) format.
(Get 15% Discount on Buying this Report)
A full report of Cell Based Assay Market is available at: https://www.orionmarketreports.com/cell-based-assays-market/44697/
The following segmentation are covered in this report:
By End User
- Pharmaceutical & Biotechnology Companies
- Academic & Government Research Institutes
- Contract Research Organizations
- Others
By Application
- Drug Discovery
- Basic Research
- ADME Studies
- Predictive Toxicology
- Others
Company Profile
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Corning Inc.
- Danaher Corporation
- Thermo Fisher Scientific Inc.
- Hoffmann-La Roche Ltd
- Merck KGaA
- Perkin Elmer Inc.
- Promega Corporation
The report covers the following objectives:
- Proliferation and maturation of trade in the global Cell Based Assay Market
- The market share of the global Cell Based Assay Market supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the Cell Based Assay Market
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Cell Based Assay Market
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
